119 related articles for article (PubMed ID: 7916736)
1. Hydroxymethylbilane synthase: complete genomic sequence and amplifiable polymorphisms in the human gene.
Yoo HW; Warner CA; Chen CH; Desnick RJ
Genomics; 1993 Jan; 15(1):21-9. PubMed ID: 7916736
[TBL] [Abstract][Full Text] [Related]
2. Molecular basis of acute intermittent porphyria: mutations and polymorphisms in the human hydroxymethylbilane synthase gene.
Astrin KH; Desnick RJ
Hum Mutat; 1994; 4(4):243-52. PubMed ID: 7866402
[TBL] [Abstract][Full Text] [Related]
3. Acute intermittent porphyria: a single-base deletion and a nonsense mutation in the human hydroxymethylbilane synthase gene, predicting truncations of the enzyme polypeptide.
Lee GY; Astrin KH; Desnick RJ
Am J Med Genet; 1995 Aug; 58(2):155-8. PubMed ID: 8533808
[TBL] [Abstract][Full Text] [Related]
4. Identification and characterization of hydroxymethylbilane synthase mutations causing acute intermittent porphyria: evidence for an ancestral founder of the common G111R mutation.
De Siervi A; Rossetti MV; Parera VE; Astrin KH; Aizencang GI; Glass IA; Batlle AM; Desnick RJ
Am J Med Genet; 1999 Oct; 86(4):366-75. PubMed ID: 10494093
[TBL] [Abstract][Full Text] [Related]
5. Acute intermittent porphyria--impact of mutations found in the hydroxymethylbilane synthase gene on biochemical and enzymatic protein properties.
Ulbrichova D; Hrdinka M; Saudek V; Martasek P
FEBS J; 2009 Apr; 276(7):2106-15. PubMed ID: 19292878
[TBL] [Abstract][Full Text] [Related]
6. Molecular analysis of acute intermittent porphyria: mutation screening in 20 patients in Germany reveals 11 novel mutations.
von Brasch L; Zang C; Haverkamp T; Schlechte H; Heckers H; Petrides PE
Blood Cells Mol Dis; 2004; 32(2):309-14. PubMed ID: 15003823
[TBL] [Abstract][Full Text] [Related]
7. Genomic organization of the human beta-catenin gene (CTNNB1).
Nollet F; Berx G; Molemans F; van Roy F
Genomics; 1996 Mar; 32(3):413-24. PubMed ID: 8838805
[TBL] [Abstract][Full Text] [Related]
8. The human Nramp2 gene: characterization of the gene structure, alternative splicing, promoter region and polymorphisms.
Lee PL; Gelbart T; West C; Halloran C; Beutler E
Blood Cells Mol Dis; 1998 Jun; 24(2):199-215. PubMed ID: 9642100
[TBL] [Abstract][Full Text] [Related]
9. [Three new mutations in the porphobilinogen deaminase gene, detected in acute intermittent porphyria patients from Russia].
Surin VL; Luk'ianenko AV; Karpova IV; Misiurin AV; Pustovot IaS; Pivnik AV
Genetika; 2001 May; 37(5):690-7. PubMed ID: 11436563
[TBL] [Abstract][Full Text] [Related]
10. Identification of acute intermittent porphyria carriers by molecular biologic methods.
Bor M; Balogh K; Pusztai A; Tasnádi G; Hunyady L
Acta Physiol Hung; 1999; 86(2):147-53. PubMed ID: 10741873
[TBL] [Abstract][Full Text] [Related]
11. Cloning, characterisation and identification of several polymorphisms in the promoter region of the human alpha2B-adrenergic receptor gene.
Cayla C; Heinonen P; Viikari L; Schaak S; Snapir A; Bouloumié A; Karvonen MK; Pesonen U; Scheinin M; Paris H
Biochem Pharmacol; 2004 Feb; 67(3):469-78. PubMed ID: 15037199
[TBL] [Abstract][Full Text] [Related]
12. Identification and expression of mutations in the hydroxymethylbilane synthase gene causing acute intermittent porphyria (AIP).
Solis C; Lopez-Echaniz I; Sefarty-Graneda D; Astrin KH; Desnick RJ
Mol Med; 1999 Oct; 5(10):664-71. PubMed ID: 10602775
[TBL] [Abstract][Full Text] [Related]
13. Acute intermittent porphyria: vector optimization for gene therapy.
Yasuda M; Domaradzki ME; Armentano D; Cheng SH; Bishop DF; Desnick RJ
J Gene Med; 2007 Sep; 9(9):806-11. PubMed ID: 17654633
[TBL] [Abstract][Full Text] [Related]
14. New mutations of the hydroxymethylbilane synthase gene in German patients with acute intermittent porphyria.
Gross U; Puy H; Doss M; Robreau AM; Nordmann Y; Doss MO; Deybach JC
Mol Cell Probes; 1999 Dec; 13(6):443-7. PubMed ID: 10657149
[TBL] [Abstract][Full Text] [Related]
15. Isolation and molecular characterization of the porcine stearoyl-CoA desaturase gene.
Ren J; Knorr C; Huang L; Brenig B
Gene; 2004 Sep; 340(1):19-30. PubMed ID: 15556291
[TBL] [Abstract][Full Text] [Related]
16. Characterization of the infection-responsive bovine lactoferrin promoter.
Zheng J; Ather JL; Sonstegard TS; Kerr DE
Gene; 2005 Jun; 353(1):107-17. PubMed ID: 15935571
[TBL] [Abstract][Full Text] [Related]
17. Diagnostic strategy, genetic diagnosis and identification of new mutations in intermittent porphyria by denaturing gradient gel electrophoresis.
Nissen H; Petersen NE; Mustajoki S; Hansen TS; Mustajoki P; Kauppinen R; Hørder M
Hum Mutat; 1997; 9(2):122-30. PubMed ID: 9067752
[TBL] [Abstract][Full Text] [Related]
18. The structure of the human dihydrolipoamide dehydrogenase gene (DLD) and its upstream elements.
Feigenbaum AS; Robinson BH
Genomics; 1993 Aug; 17(2):376-81. PubMed ID: 8406489
[TBL] [Abstract][Full Text] [Related]
19. Sequence of human tryptophan 2,3-dioxygenase (TDO2): presence of a glucocorticoid response-like element composed of a GTT repeat and an intronic CCCCT repeat.
Comings DE; Muhleman D; Dietz G; Sherman M; Forest GL
Genomics; 1995 Sep; 29(2):390-6. PubMed ID: 8666386
[TBL] [Abstract][Full Text] [Related]
20. Human periplakin: genomic organization in a clonally unstable region of chromosome 16p with an abundance of repetitive sequence elements.
Aho S; Rothenberger K; Tan EM; Ryoo YW; Cho BH; McLean WH; Uitto J
Genomics; 1999 Mar; 56(2):160-8. PubMed ID: 10051401
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
